40 results
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
-Immune Biotech, Inc., Tokyo, Japan, a biotechnology company focusing on the development of innovative cancer immunotherapies, today announced … collaborations to apply PRIME technology, which was invented by Dr. Koji Tamada, our scientific founder, to highly innovative cell therapies, and to work
8-K
ADAP
Adaptimmune Therapeutics Plc
15 May 19
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
8:11am
Agreement”) with Alpine Immune Sciences, Inc. (“Alpine”), a leading clinical-stage immunotherapy company focused on developing innovative treatments
8-K
ADAP
Adaptimmune Therapeutics Plc
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
of Immunomedics, Inc., an innovative biopharmaceutical company that focuses on novel immunotherapeutics for the treatment of cancer, autoimmune and other
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
14 Jan 20
Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
6:17am
the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information, please visit our
6-K
EX-99.3
ADAP
Adaptimmune Therapeutics Plc
9 Oct 15
Adaptimmune announces New Research and Development Facility in Oxfordshire
12:00am
with Adaptimmune to design a flexible and innovative facility that accommodates its very specific requirements while creating an exciting and inspiring
8-K
EX-99.2
e3ivp57obuflbb
10 Apr 17
Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering
12:00am
8-K
EX-99.1
t15qcij6c025
9 Sep 22
Adaptimmune Reports Positive Data in its SURPASS Trial; Outlines Plans for Advanced Clinical Development in Multiple MAGE-A4 Positive Solid Tumors
7:14am
8-K
EX-10.1
rn5ziud3zdy
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
10-K
EX-10.16
liawv8mn7qd1 zmjx1g
13 Mar 17
Annual report
12:00am